期刊文献+

60例局部复发性骨肉瘤患者的预后影响因素分析(英文)

Retrospective analysis of prognostic factors for sixty osteosarcoma patients with local recurrence
下载PDF
导出
摘要 Objective:The aim of this study was to identify prognostic factors and imply the appropriate management for local recurrent osteosarcoma.Methods:The clinical records of 60 patients with local recurrence osteosarcoma were reviewed between January 2002 and December 2010.The mean followed-up time for these patients was 49.1 months(range 13 to 143 months).The factors of age,gender,tumor site,tumor size,surgical procedure,neoadjuvant chemotherapy,frequency of primary postoperative adjuvant chemotherapy,lung metastasis,metastasis of other sites(except for lung) and treatment after local recurrence were selected as the measurements for this analysis.Kaplan-Meier method was used to measure the overall survival and post-recurrence survival.The univariate analysis was used to determine the prognostic factors related with survival by Log-rank test.The COX proportional-hazard regression model was used to analyze the correlation between the prognostic factor and the survival.Results:The median post-recurrence survival and overall survival of 60 patients were 32 months(95% confidence interval:16.2-47.8) and 55 months(95% confidence interval:39.3-70.7) respectively.The 2and 3-year cumulative survival rates were 81.7% and 55.4%,respectively.The Log-rank univariate analysis showed that age,gender,tumor size,metastasis of other sites(except for lung) and treatment after local recurrence were associated with the prognosis of osteosarcoma with local recurrence(P < 0.05).The Cox regression analysis revealed that gender(P = 0.016),metastasis of other sites(except for lung,P = 0.017) and treatment after local recurrence(P = 0.028) were the independent prognostic factors of osteosarcoma with local recurrence.On the other hand,the prognosis of local recurrent osteosarcoma was not associated with tumor site,surgical procedure,frequency of primary postoperative adjuvant chemotherapy,neoadjuvant chemotherapy and lung metastasis(P > 0.05).Conclusion:The independent prognostic factors for local recurrent osteosarcoma were the metastasis of other site(except for lung) and the treatment after local recurrence.The aggressive surgical treatment for local recurrence and distant metastasis could effectively improve the survival of local recurrent osteosarcoma. Objective: The aim of this study was to identify prognostic factors and imply the appropriate management for lo- cal recurrent osteosarcoma. Methods: The clinical records of 60 patients with local recurrence osteosarcoma were reviewed between January 2002 and December 2010. The mean followed-up time for these patients was 49.1 months (range 13 to 143 months). The factors of age, gender, tumor site, tumor size, surgical procedure, neoadjuvant chemotherapy, frequency of primary postoperative adjuvant chemotherapy, lung metastasis, metastasis of other sites (except for lung) and treatment after local recurrence were selected as the measurements for this analysis. Kaplan-Meier method was used to measure the overall survival and post-recurrence survival. The univariate analysis was used to determine the prognostic factors related with survival by Log-rank test. The COX proportional-hazard regression model was used to analyze the correlation between the prognostic factor and the survival. Results: The median post-recurrence survival and overall survival of 60 patients were 32 months (95% confidence interval: 16.2-47.8) and 55 months (95% confidence interval: 39.3-70.7) respectively. The 2- and 3-year cumulative survival rates were 81.7% and 55.4%, respectively. The Log-rank univariate analysis showed that age, gender, tumor size, metastasis of other sites (except for lung) and treatment after local recurrence were associated with the prognosis of osteosarcoma with local recurrence (P 〈 0.05). The Cox regression analysis revealed that gender (P = 0.016), metastasis of other sites (except for lung, P = 0.017) and treatment after local recurrence (P = 0.028) were the independent prognostic factors of osteosarcoma with local recurrence. On the other hand, the prognosis of local recurrent osteosarcoma was not associated with tumor site, surgical procedure, frequency of primary postoperative adjuvant chemo- therapy, neoadjuvant chemotherapy and lung metastasis (P 〉 0.05). Conclusion: The independent prognostic factors for local recurrent osteosarcoma were the metastasis of other site (except for lung) and the treatment after local recurrence. The aggressive surgical treatment for local recurrence and distant metastasis could effectively improve the survival of local recurrent osteosarcoma.
机构地区 Department of Oncology
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第3期123-128,共6页 中德临床肿瘤学杂志(英文版)
关键词 骨肉瘤 复发 预后 患者 手术治疗 单因素分析 手术过程 可信区间 osteosarcoma local recurrence prognosis
  • 相关文献

参考文献3

二级参考文献27

  • 1蒋智铭,张惠箴,陈洁晴,黄瑾,刘亮.骨肉瘤的组织学类型[J].临床与实验病理学杂志,2004,20(3):263-266. 被引量:15
  • 2PICCI P.Osteosarcoma (osteogenic sarcoma)[J].Orphanet J Rare Dis,2007,2:6.
  • 3EKE T,OJAIMI J,KITAGAWA Y,et al.Outcome of patients with osteosarcoma over 40 years of age:Is angiogenesis a marker of survival[J].Int Semin Surg Oncol,2006,3:7.
  • 4GRIMER R I,CANNON S R,TAMINIAU A M,et al.Osteosarcoma over the age of forty[J].Eur J Cancer,2003,39 (2):157-163.
  • 5CARSI B,ROCK M G.Primary osteosarcoma in adults older than 40 years[J].Clin Orthop Relat Res,2002,Apr (397):53-61.
  • 6BROOKS S,STARKIE C M,CLARKE N M.Osteosarcoma after the fourth decade.A clinico-pathological review[J].Arch Orthop Trauma Surg,1985,104 (2):100-105.
  • 7SONG W S,KONG C B,JEON D G,et al.Prognosis of extremity osteosarcoma in patients aged 40-60 years:A cohort/case controlled study at a single institute[J].Eur J Surg Oncol,2010,36 (5):483-488.
  • 8NISHIDA Y,ISU K,UEDA T,et al.Osteosarcoma in the elderly over 60 years:a multicenter study by the Japanese Musculoskeletal Oncology Group[J].J Surg Oncol,2009,100 (1):48-54.
  • 9BIELACK S S,KEMPF-BIELACK B,HEISE U,et al.Combined modality treatment for osteosarcoma occurring as a second malignant disease.Cooperative Germane Austrian Swiss Osteosarcoma Study Group[J].J Clin Oncol,1999,17 (4):1164.
  • 10JAFFE N.Recent advances in the chemotherapy of metastatic osteogenic sarcoma[J].Cancer,1972,30 (6):1627-1631.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部